Background. Treatment of late-stage human African typanosomiasis (HAT) with melarsoprol can be improved by shortening the regimen. A previous trial demonstrated the safety and efficacy of a 10-day ...

A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...

Aug. 25, 2005 (Vernon Hills, Ill.) — Immtech International, Inc. announced today that it has initiated, in partnership with the University of North Carolina at Chapel Hill, a Phase III pivotal trial ...

African trypanosomiasis (also known as sleeping sickness) is a disease transmitted by tsetse flies and is fatal to humans and other animals; however, there is currently no vaccine, this disease is ...

Human African trypanosomiasis (HAT), commonly referred to as sleeping sickness, is a protozoan parasitic infection transmitted by the tsetse fly. Its two causative agents, Trypansoma brucei gambiense ...

Novartis AG has synthesized cyanotrizole compounds reported to be useful for the treatment of leishmaniasis, American trypanosomiasis (Chagas disease) and African trypanosomiasis (sleeping sickness).

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. * The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A single dose of ...

A herdsman sprays cattle with insecticide to prevent tsetse fly infestation during the Kenya Tsetse and Trypanosomiasis Eradication Council visit to tsetse fly-prone areas in Kina, Isiolo county.